These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 20101720)

  • 41. Alzheimer--certitudes and hypotheses.
    Amihăesei IC; Cojocarut E; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):119-26. PubMed ID: 24505903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
    Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts.
    Giannakopoulos P; Hof PR; Michel JP; Guimon J; Bouras C
    Brain Res Brain Res Rev; 1997 Oct; 25(2):217-45. PubMed ID: 9403139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurofibrillary tangles and Alzheimer's disease.
    Brion JP
    Eur Neurol; 1998 Oct; 40(3):130-40. PubMed ID: 9748670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.
    Paulson JB; Ramsden M; Forster C; Sherman MA; McGowan E; Ashe KH
    Am J Pathol; 2008 Sep; 173(3):762-72. PubMed ID: 18669616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T Lymphocytes in the Pathogenesis and Progression of Alzheimer's Disease: Pursuing Direct Neuropathological Evidence.
    Han PC; Hamlett ED
    Curr Alzheimer Res; 2023; 20(7):453-458. PubMed ID: 37670715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging concepts in Alzheimer's disease.
    Vinters HV
    Annu Rev Pathol; 2015; 10():291-319. PubMed ID: 25387055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new kind of Alzheimer's disease plaque.
    Baum L; Ng HK
    Adv Anat Pathol; 1998 May; 5(3):170-4. PubMed ID: 9868523
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
    Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's disease: critical notes on the history of a medical concept.
    Ramirez-Bermudez J
    Arch Med Res; 2012 Nov; 43(8):595-9. PubMed ID: 23178566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
    Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
    Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.